急性缺血性卒中取栓中一线支架与补救支架的倾向加权比较
基于RESISTANT多中心回顾性登记(2016-2023年),827例取栓中行颅内支架的患者按一线支架(FLS,104例)或补救支架(RS,723例)分组,经倾向评分逆概率加权后,FLS与RS在90天功能独立和症状性颅内出血上均无显著差异。
要点
- FLS与RS的90天功能独立无显著差异(OR 0.64,95%CI 0.38-1.07)。
- 症状性颅内出血风险两组相当(OR 0.93,95%CI 0.34-2.59)。
- 前循环与后循环亚组中两策略的安全性和有效性亦无显著差异。
核心结论
- 在急性缺血性卒中取栓中,一线支架与补救支架策略的安全性和有效性未检测到显著差异。
研究设计与样本
- 多中心、国际、回顾性队列RESISTANT登记,纳入2016-2023年取栓中行颅内支架的急性缺血性卒中患者827例。
- 按支架策略分为一线支架组(FLS,104例)和补救支架组(RS,723例),采用倾向评分逆概率加权调整基线差异。
主要发现
- RS组中位年龄67岁(IQR 59-77),男性64.2%;FLS组中位年龄65.5岁(IQR 58.8-77),男性72.1%。
- 以FLS为参照,加权后功能独立OR 0.64(95%CI 0.38-1.07),症状性颅内出血OR 0.93(95%CI 0.34-2.59)。
- 成功再灌注、死亡或操作并发症等次要结局均无显著差异。
- 前循环亚组(n=589)功能独立OR 0.62(95%CI 0.60-1.25),症状性颅内出血OR 0.81(95%CI 0.30-2.18)。
- 后循环亚组(n=234)功能独立OR 0.82(95%CI 0.32-2.10),症状性颅内出血OR 0.81(95%CI 0.30-2.18)。
临床怎么用
- 对于取栓中需行颅内支架的患者,一线支架与补救支架均可作为可选策略,需个体化权衡。
- 研究结果提示两种策略的安全性和有效性相当,但需前瞻性随机试验进一步明确最优方案。
局限性
- 本研究为回顾性队列研究,存在选择偏倚等固有局限。
- FLS组样本量较小(104例),可能影响统计效能。
- 作者指出需前瞻性随机试验以更好定义最佳治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While rescue stenting (RS) is a recognized bailout strategy following failed endovascular thrombectomy for acute ischemic stroke with large vessel occlusion, first-line stenting (FLS) has emerged as a potential alternative to avoid vascular injury and improve outcomes. However, direct comparisons between these strategies remain limited. We conducted a comparative analysis of FLS versus RS using data from a large, multicenter international registry to evaluate their relative safety and effectiveness. METHODS: We conducted a comparative analysis of FLS versus RS using data from the RESISTANT registry (Registry of Endovascular Salvage for Intracranial Stenting in Thrombectomy-Refractory Stroke), a multicenter, international, retrospective cohort of patients with acute ischemic stroke treated with intracranial stenting during endovascular thrombectomy (2016-2023). Patients were categorized by stenting strategy: FLS (stent placed without prior thrombectomy) or RS (stent placed after failed thrombectomy). The primary effectiveness outcome was functional independence (modified Rankin Scale score, 0-2) at 90 days; the primary safety outcome was symptomatic intracranial hemorrhage. Propensity score inverse probability of treatment weighting was used to adjust for baseline differences. RESULTS: Among 827 patients, 723 were in the RS cohort (median age, 67 [interquartile range, 59-77] years; 64.2% male) and 104 in the FLS cohort (median age, 65.5 [interquartile range, 58.8-77] years; 72.1% male). Using FLS as the reference strategy, inverse probability of treatment weighting-adjusted analyses did not detect significant differences in functional independence (odds ratio [OR], 0.64 [95% CI, 0.38-1.07]) or symptomatic intracranial hemorrhage (OR, 0.93 [95% CI, 0.34-2.59]). No significant differences were observed in secondary outcomes, including successful reperfusion, mortality, or procedural complications. In the anterior circulation cohort (n=589), outcomes were likewise comparable (functional independence: OR, 0.62 [95% CI, 0.60-1.25]; symptomatic intracranial hemorrhage: OR, 0.81 [95% CI, 0.30-2.18]). Similarly, in the posterior circulation cohort (n=234), no significant differences were found (functional independence: OR, 0.82 [95% CI, 0.32-2.10]; symptomatic intracranial hemorrhage: OR, 0.81 [95% CI, 0.30-2.18]). CONCLUSIONS: In this study, no significant differences in safety or effectiveness were detected between FLS and RS strategies during endovascular thrombectomy for acute ischemic stroke. Prospective, randomized trials are needed to better define optimal treatment approaches.
引用
- Rodriguez-Calienes A, Yavagal DR, Asdaghi N, et al. Rescue Versus First-Line Intracranial Stenting During Thrombectomy for Acute Ischemic Stroke: A Propensity-Weighted Analysis of the RESISTANT Registry. Stroke. 2026. PMID: 41608810. doi:10.1161/STROKEAHA.125.054467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。